680 related articles for article (PubMed ID: 31587793)
61. Perioperative Cardiothoracic and Vascular Risk in Childhood Cancer and its Survivors.
Ketterl TG; Latham GJ
J Cardiothorac Vasc Anesth; 2021 Jan; 35(1):162-175. PubMed ID: 32360009
[TBL] [Abstract][Full Text] [Related]
62. Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer. The Provincial Systemic Treatment Disease Site Group.
Seymour L; Bramwell V; Moran LA
Cancer Prev Control; 1999 Apr; 3(2):145-59. PubMed ID: 10474762
[TBL] [Abstract][Full Text] [Related]
63. Cardio-oncology for Pediatric and Adolescent/Young Adult Patients.
Tolani D; Wilcox J; Shyam S; Bansal N
Curr Treat Options Oncol; 2023 Aug; 24(8):1052-1070. PubMed ID: 37296365
[TBL] [Abstract][Full Text] [Related]
64. Cardio-oncology: management of cardiovascular toxicity.
Markman TM; Markman M
F1000Res; 2019; 8():. PubMed ID: 30755794
[TBL] [Abstract][Full Text] [Related]
65. Echocardiography and Cardio-Oncology.
Negishi T; Miyazaki S; Negishi K
Heart Lung Circ; 2019 Sep; 28(9):1331-1338. PubMed ID: 31230869
[TBL] [Abstract][Full Text] [Related]
66. [How to organise cardiovascular management of cancer patients?].
Thuny F; Cautela J
Rev Prat; 2018 Mar; 68(3):332-335. PubMed ID: 30869302
[TBL] [Abstract][Full Text] [Related]
67. Cardiovascular Disease in Adult Cancer Survivors: a Review of Current Evidence, Strategies for Prevention and Management, and Future Directions for Cardio-oncology.
Muhandiramge J; Zalcberg JR; van Londen GJ; Warner ET; Carr PR; Haydon A; Orchard SG
Curr Oncol Rep; 2022 Nov; 24(11):1579-1592. PubMed ID: 35796941
[TBL] [Abstract][Full Text] [Related]
68. Cardiovascular safety of oncologic agents: A double-edged sword even in the era of targeted therapies - part 1.
Manolis AA; Manolis TA; Mikhailidis DP; Manolis AS
Expert Opin Drug Saf; 2018 Sep; 17(9):875-892. PubMed ID: 30126304
[TBL] [Abstract][Full Text] [Related]
69. Cardio-oncology: the new frontier of clinical and preventive cardiology.
Paris S; Tarantini L; Navazio A; Faggiano P
Monaldi Arch Chest Dis; 2020 Jun; 90(2):. PubMed ID: 32571000
[TBL] [Abstract][Full Text] [Related]
70. The Role of Imaging with Cardiac Computed Tomography in Cardio-Oncology Patients.
Pitekova B; Ravi S; Shah SV; Mladosievicova B; Heitner S; Ferencik M
Curr Cardiol Rep; 2016 Sep; 18(9):87. PubMed ID: 27443383
[TBL] [Abstract][Full Text] [Related]
71. Organization and implementation of a cardio-oncology program.
Fiuza M; Ribeiro L; Magalhães A; Sousa AR; Nobre Menezes M; Jorge M; Costa L; Pinto FJ
Rev Port Cardiol; 2016 Sep; 35(9):485-94. PubMed ID: 27503589
[TBL] [Abstract][Full Text] [Related]
72. The Role of CYP450 Drug Metabolism in Precision Cardio-Oncology.
Fatunde OA; Brown SA
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963461
[TBL] [Abstract][Full Text] [Related]
73. Modeling Precision Cardio-Oncology: Using Human-Induced Pluripotent Stem Cells for Risk Stratification and Prevention.
Perry TR; Roberts ML; Sunkara B; Maddula R; McLeish T; Gomez J; Lucas J; Rayan D; Patel S; Liang M; Bosnjak ZJ; Brown SA
Curr Oncol Rep; 2021 May; 23(7):77. PubMed ID: 33937943
[TBL] [Abstract][Full Text] [Related]
74. Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy.
Virani SA; Dent S; Brezden-Masley C; Clarke B; Davis MK; Jassal DS; Johnson C; Lemieux J; Paterson I; Sebag IA; Simmons C; Sulpher J; Thain K; Thavendiranathan P; Wentzell JR; Wurtele N; Côté MA; Fine NM; Haddad H; Hayley BD; Hopkins S; Joy AA; Rayson D; Stadnick E; Straatman L
Can J Cardiol; 2016 Jul; 32(7):831-41. PubMed ID: 27343741
[TBL] [Abstract][Full Text] [Related]
75. Cancer survivorship: cardiotoxic therapy in the adult cancer patient; cardiac outcomes with recommendations for patient management.
Steingart RM; Yadav N; Manrique C; Carver JR; Liu J
Semin Oncol; 2013 Dec; 40(6):690-708. PubMed ID: 24331191
[TBL] [Abstract][Full Text] [Related]
76. Cardiovascular Toxicity and Risk Mitigation with Lung Cancer Treatment.
Yegya-Raman N; Berlin E; Feigenberg SJ; Ky B; Sun L
Curr Oncol Rep; 2023 May; 25(5):433-444. PubMed ID: 36811807
[TBL] [Abstract][Full Text] [Related]
77. Anthracycline cardiotoxicity in childhood.
Ruggiero A; Ridola V; Puma N; Molinari F; Coccia P; De Rosa G; Riccardi R
Pediatr Hematol Oncol; 2008 Jun; 25(4):261-81. PubMed ID: 18484471
[TBL] [Abstract][Full Text] [Related]
78. Acquired and modifiable cardiovascular risk factors in patients treated for cancer.
Beasley GS; Towbin JA
J Thromb Thrombolysis; 2021 May; 51(4):846-853. PubMed ID: 32918669
[TBL] [Abstract][Full Text] [Related]
79. [Cardiovascular complications of cancers and anti-cancer therapy].
Vyskočil J; Petráková K; Jelínek P; Furdek M
Vnitr Lek; 2017; 63(3):200-209. PubMed ID: 28379023
[TBL] [Abstract][Full Text] [Related]
80. [Drugs cardiotoxicity].
Capilla E; Poyet R; Brocq FX; Pons F; Kerebel S; Jego C; Laurent P; Cellarier GR
Presse Med; 2015 Oct; 44(10):995-1002. PubMed ID: 26153088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
